The current valuation score of Palisade Bio Inc is 6.71, ranking 263 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is 16.09, which is 17.68% below the recent high of 18.93 and 157.73% above the recent low of -9.29.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.